In This Issue: The Trump administration announced it is ending all NIH funding for research using tissue from aborted babies, effective immediately. The policy applies across all NIH grants and programs, expanding on Trump’s first-term ban on intramural fetal tissue research. NIH Director Jay Bhattacharya said ethical alternatives now make such research unnecessary.
In This Issue: Taiwan has broken the record for world’s lowest birth rate, according to newly released government data. Births fell for the 10th consecutive year, with just 107,812 newborns in 2025, a 20% drop from 2024. Taiwan’s birth rate stands at 4.62 per 1,000 people, with its total fertility rate estimated at around 0.72, despite recent government subsidies aimed at boosting births.
In This Issue: New research from the Institute for Family Studies finds a widening divide in marriage and childbearing, with liberal young adults increasingly less likely to form families. The analysis shows that even liberal adults report higher happiness when married with children, yet family formation is declining fastest on the Left. The trend has demographic consequences: Since 2000, states that voted for Donald Trump in 2024 have seen their child population rise about 7%, while states that voted for Kamala Harris have seen theirs fall by roughly 7%.
In This Issue: The European Parliament has voted to advance a proposal that would use EU taxpayer funds to pay for abortions abroad for women from countries with pro-life laws, including Poland and Malta. The nonbinding measure passed 358 to 202 and would override national protections by encouraging abortion tourism across member states. The scheme undermines national sovereignty, parental protections, and Europe’s Christian moral heritage.
In This Issue: PRI’s Latin American office is proud to report that the Peruvian Congress has passed a new law on equal opportunity between men and women that respects the biological reality that there are only two sexes. This is a huge victory for Peru and for PRI, which provided the intellectual “muscle” behind this effort. The new law throws out the “gender ideology” concept that was forced on Peru by Obama’s USAID and which has been the guiding principle of Peruvian governments since 2014.
In This Issue: A Scottish Government-commissioned review—led by a former trustee of the UK’s largest abortion provider—is advocating for the scrapping of Scotland’s 24-week abortion limit. This would allow abortions on “social grounds,” including sex-selective abortions, up to birth. In 2024, 98% of Scotland’s 18,710 abortions were performed under a clause interpreted to allow abortion for social reasons.
In This Issue: Switzerland’s fertility rate has fallen to 1.29 children per woman, the lowest level since records began, according to new data from the Federal Statistical Office. Births of third children fell 13.6% in 2024, while first and second births have declined 8.5% and 9% respectively since 2019. Women aged 35–39 now give birth more often than those aged 25–29, reflecting delayed family formation.
In This Issue: Italy’s fertility crisis has deepened, with births dropping to the lowest level since national unification in 1861. According to Italy’s statistics bureau ISTAT, only 370,000 babies were born last year—a 6.3% decline from 2024—and just 198,000 births were recorded between January and July 2025. The fertility rate has fallen to 1.13 children per woman.
In This Issue: According to a new report from the Australian Bureau of Statistics (ABS), Australia’s fertility rate has fallen to a record low of 1.48 births per woman in 2024, sparking warnings that the nation is nearing a “point of no return.” Women aged 30–34 recorded the highest fertility rate—106 births per 1,000 women, a slight rise from the previous year.
In This Issue: The FDA, under Trump appointee Dr. Marty Makary, has approved new generic abortion pills made by Evita Solution, a company that openly seeks to “normalize abortion” and make it “accessible to all.” Despite promises of a full safety review of the chemical abortion drug, the FDA instead fast-tracked approval, prompting outrage from U.S. Sen. Josh Hawley.
In This Issue: The Trump administration announced it is ending all NIH funding for research using tissue from aborted babies, effective immediately. The policy applies across all NIH grants and programs, expanding on Trump’s first-term ban on intramural fetal tissue research. NIH Director Jay Bhattacharya said ethical alternatives now make such research unnecessary.
In This Issue: Taiwan has broken the record for world’s lowest birth rate, according to newly released government data. Births fell for the 10th consecutive year, with just 107,812 newborns in 2025, a 20% drop from 2024. Taiwan’s birth rate stands at 4.62 per 1,000 people, with its total fertility rate estimated at around 0.72, despite recent government subsidies aimed at boosting births.
In This Issue: New research from the Institute for Family Studies finds a widening divide in marriage and childbearing, with liberal young adults increasingly less likely to form families. The analysis shows that even liberal adults report higher happiness when married with children, yet family formation is declining fastest on the Left. The trend has demographic consequences: Since 2000, states that voted for Donald Trump in 2024 have seen their child population rise about 7%, while states that voted for Kamala Harris have seen theirs fall by roughly 7%.
In This Issue: The European Parliament has voted to advance a proposal that would use EU taxpayer funds to pay for abortions abroad for women from countries with pro-life laws, including Poland and Malta. The nonbinding measure passed 358 to 202 and would override national protections by encouraging abortion tourism across member states. The scheme undermines national sovereignty, parental protections, and Europe’s Christian moral heritage.
In This Issue: PRI’s Latin American office is proud to report that the Peruvian Congress has passed a new law on equal opportunity between men and women that respects the biological reality that there are only two sexes. This is a huge victory for Peru and for PRI, which provided the intellectual “muscle” behind this effort. The new law throws out the “gender ideology” concept that was forced on Peru by Obama’s USAID and which has been the guiding principle of Peruvian governments since 2014.
In This Issue: A Scottish Government-commissioned review—led by a former trustee of the UK’s largest abortion provider—is advocating for the scrapping of Scotland’s 24-week abortion limit. This would allow abortions on “social grounds,” including sex-selective abortions, up to birth. In 2024, 98% of Scotland’s 18,710 abortions were performed under a clause interpreted to allow abortion for social reasons.
In This Issue: Switzerland’s fertility rate has fallen to 1.29 children per woman, the lowest level since records began, according to new data from the Federal Statistical Office. Births of third children fell 13.6% in 2024, while first and second births have declined 8.5% and 9% respectively since 2019. Women aged 35–39 now give birth more often than those aged 25–29, reflecting delayed family formation.
In This Issue: Italy’s fertility crisis has deepened, with births dropping to the lowest level since national unification in 1861. According to Italy’s statistics bureau ISTAT, only 370,000 babies were born last year—a 6.3% decline from 2024—and just 198,000 births were recorded between January and July 2025. The fertility rate has fallen to 1.13 children per woman.
In This Issue: According to a new report from the Australian Bureau of Statistics (ABS), Australia’s fertility rate has fallen to a record low of 1.48 births per woman in 2024, sparking warnings that the nation is nearing a “point of no return.” Women aged 30–34 recorded the highest fertility rate—106 births per 1,000 women, a slight rise from the previous year.
In This Issue: The FDA, under Trump appointee Dr. Marty Makary, has approved new generic abortion pills made by Evita Solution, a company that openly seeks to “normalize abortion” and make it “accessible to all.” Despite promises of a full safety review of the chemical abortion drug, the FDA instead fast-tracked approval, prompting outrage from U.S. Sen. Josh Hawley.